Cell Counting Market - Global Forecast to 2023: Growing Use of High-Throughput Flow Cytometry and Automated Hematology Analyzers
DUBLIN, Feb. 14, 2019 /PRNewswire/ --
The "Cell Counting Market by Product (Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer), Consumables), End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global cell counting market is projected to reach USD 12.32 billion by 2023 from USD 8.84 billion in 2018, at a CAGR of 6.8%.
Factors contributing to the growth of this market include growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.
The report analyzes the global cell counting market by product, application, end user, and region. On the basis of product, the consumables segment is expected to account for the largest share of the market in 2018. The large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures. The growing focus on stem cell and cancer research is one of the major drivers for the growth of the cell counting consumables market during the forecast period. In addition, the growing application of cell counting in quality control procedures in various industries such as food and beverage, pharmaceutical, and biotechnology products manufacturing, and in the field of environmental monitoring and water treatment is also expected to play a key role in the growth of the cell counting consumables market during the forecast period.
Based on application, the research applications segment is expected to account for the largest share of the global cell counting market in 2018. The large share of this segment can be attributed to the growing adoption of various cell counting instruments in research activities propelled by increasing research activities being undertaken for cancer, immunology, infectious diseases, HIV, drug discovery, and stem cells.
Based on end user, the hospitals segment is expected to register the highest CAGR during the forecast period. This can be attributed to the large adoption of cell counting equipment for the diagnosis and treatment of several diseases along with the continuous consumption of consumables.
Geographically, the global cell counting market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to account for the largest share of the cell counting market, followed by Europe and Asia Pacific. The dominance of the North American region can be attributed to the growing incidence of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research. Various additional advantages such as the availability of insurance coverage for laboratory testing procedures, rising healthcare and R&D expenditure, and the presence of well-structured distribution channels in the region are also supporting the growth of the market.
Key Topics Covered:
1 Cell Counting Market: Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Stakeholders
1.6 Limitations
2 Cell Counting Market: Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Cell Counting Market: Executive Summary
4 Cell Counting Market: Premium Insights
4.1 Cell Counting Market Overview
4.2 Cell Counting Market: Geographic Growth Opportunities
4.3 Regional Mix: Cell Counting Market (2018-2023)
4.4 Asia Pacific: Cell Counting Instruments Market, By Type (2017)
4.5 Cell Counting Market: Developed vs Developing Markets
5 Cell Counting Market: Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Incidence of Target Diseases and Blood Disorders
5.2.1.2 Development of Enhanced Solutions and Improved Image Analysis
5.2.1.3 Growing Use of High-Throughput Flow Cytometry and Automated Hematology Analyzers
5.2.2 Market Restraints
5.2.2.1 High Cost of Advanced Cell Counting Systems
5.2.2.2 Product Recalls of Hematology Analyzers
5.2.3 Market Opportunities
5.2.3.1 Growing Focus on Stem Cell Research
5.2.3.2 Emerging Economies
5.2.4 Market Challenges
5.2.4.1 Inadequate Infrastructure for Research in Emerging Countries
5.2.4.2 Dearth of Skilled Professionals in Clinical Laboratories
6 Cell Counting Market: Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Demand for Small Automated Cell Counting Instruments
6.2.2 Integration of Hematology Analyzers With Flow Cytometry
6.3 Value Chain Analysis
6.4 Parent Market Analysis
7 Cell Counting Market, By Product
7.1 Introduction
7.2 Consumables
7.2.1 Media, Sera, & Reagents
7.2.2 Assay Kits
7.2.3 Microplates
7.2.4 Accessories
7.2.5 Other Consumables
7.3 Instruments
7.3.1 Spectrophotometers
7.3.1.1 Single-Mode Readers
7.3.1.2 Multi-Mode Readers
7.3.2 Flow Cytometers
7.3.3 Hematology Analyzers
7.3.3.1 Fully Automated Analyzers
7.3.3.2 Semi-Automated Analyzers
7.3.4 Cell Counters
7.3.4.1 Automated Cell Counters
7.3.4.2 Hemocytometers/Manual Cell Counters
8 Cell Counting Market, By Application
8.1 Introduction
8.2 Research Applications
8.3 Clinical & Diagnostic Applications
8.4 Industrial Applications
9 Cell Counting Market, By End User
9.1 Introduction
9.2 Research Institutes
9.3 Pharmaceutical & Biotechnology Companies
9.4 Hospitals
9.5 Clinical Laboratories
9.6 Other End Users
10 Cell Counting Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.6 Middle East & Africa
11 Cell Counting Market: Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Market Share Analysis: Global Cell Counting Market
11.3 Product Portfolio Matrix
11.4 Competitive Situation and Trends
11.4.1 Product Launches
11.4.2 Expansions
11.4.3 Acquisitions
11.4.4 Other Strategies
12 Cell Counting Market: Company Profiles
12.1 Danaher Corporation
12.2 Thermo Fisher Scientific
12.3 Becton, Dickinson and Company
12.4 Merck
12.5 Bio-Rad Laboratories
12.6 Ge Healthcare
12.7 Perkinelmer
12.8 Biotek Instruments
12.9 Agilent Technologies
12.10 Tecan
12.11 Abbott Laboratories
12.12 Siemens Healthineers
12.13 F. Hoffmann-La Roche
12.14 Sysmex Corporation
12.15 Horiba
For more information about this report visit https://www.researchandmarkets.com/research/9nj8lw/cell_counting?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/cell-counting-market---global-forecast-to-2023-growing-use-of-high-throughput-flow-cytometry-and-automated-hematology-analyzers-300795943.html
SOURCE Research and Markets
